Hepatitis B screening proposed for all high-risk adults

Hepatitis B screening proposed for all high-risk adults
Nearly 1 million in U.S. are infected, says Preventive Services Task Force.

(HealthDay)—Adults at high risk for hepatitis B should be screened for the viral infection, according to a draft recommendation from the U.S. Preventive Services Task Force.

Although most people born in the United States are vaccinated against hepatitis B, there are still nearly 1 million infected people in the United States. Of those with B infection, 15 percent to 25 percent die from serious liver disease or liver cancer.

"The good news is that evidence shows we can catch the disease early in many people who are already infected by screening for hepatitis B virus infection in persons at high risk for infection," member Dr. Douglas Owens, a professor of medicine at Stanford University, said in a task force news release. "And treatment can help prevent in people who have chronic hepatitis B infection."

Screening consists of a blood test.

Based on a review of existing evidence, the task force concluded the following people should be screened for hepatitis B:

  • Anyone born in countries or regions with a high rate of hepatitis B infection, including Africa, Southeast Asia, the Middle East, Eastern Europe and the northern countries in South America
  • People born in the United States who were not vaccinated against hepatitis B in infancy whose parents were born in areas with a high rate of hepatitis B infection
  • Those who are HIV-positive
  • IV drug users
  • Gay and bisexual men
  • People with a weak immune system
  • Those undergoing treatment for kidney failure

Vaccination remains the best way to prevent hepatitis B infection, the panel pointed out.

"The United States has universal vaccination of all infants at birth, catch-up vaccination of adolescents and vaccination of groups. Fortunately, most people in the U.S. are no longer at risk of getting hepatitis B," task force member Dr. Mark Ebell said in the news release.

"Because some countries have high rates of [hepatitis B] infection, it is important for immigrants from those countries and their doctors to be aware of their risk status and screen them if appropriate," he added.

Public comments on this draft proposal are being accepted until March 11. The task force—an independent, advisory group of health care experts—will consider these comments in developing its final statement.

More information: The World Health Organization provides more information on hepatitis B.

Evidence Report
Draft Recommendation
Comment on Recommendation

add to favorites email to friend print save as pdf

Related Stories

New test IDs genotype of hepatitis C

Jun 20, 2013

(HealthDay)—A new test to help doctors identify the genotype of a person's hepatitis C infection has been approved by the U.S. Food and Drug Administration.

Baby boomers need hepatitis C test, CDC study confirms

Aug 15, 2013

(HealthDay)—Baby boomers—the generation known for sex, drugs and rock and roll—are the most likely Americans to develop hepatitis C, and too many of them aren't tested until it's too late to prevent ...

Recommended for you

Sri Lanka celebrates two years without malaria

19 minutes ago

Sri Lanka has not reported a local case of malaria since October 2012, according to the Sri Lankan Anti-Malarial Campaign. If it can remain malaria-free for one more year, the country will be eligible to apply to the World ...

Poll: Many doubt hospitals can handle Ebola

4 hours ago

A new poll finds most Americans have some confidence that the U.S. health care system will prevent Ebola from spreading in this country, but they're not so sure their local hospital can safely handle a patient.

Number of Ebola cases nears 10,000

4 hours ago

The number of people with Ebola is set to hit 10,000 in West Africa, the World Health Organization said, as the scramble to find a cure gathered pace.

'Breath test' shows promise for diagnosing fungal pneumonia

4 hours ago

Many different microbes can cause pneumonia, and treatment may be delayed or off target if doctors cannot tell which bug is the culprit. A novel approach—analyzing a patient's breath for key chemical compounds made by the ...

User comments